342 Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase II clinical study
Lingying Wu, Guiling Li, Youzhong Zhang, Ruifang An, Li Sun, Keqiang Zhang, Yi Huang, Ruixia Guo, Qingshui Li, Jinwei Miao, A. Lin, Jianlin Yuan, G. Lou, Hongying Yang, Yu Zhang, Hui Zhang, Aiqin He, Junying Tang, Jianming Ying, Yun Ling, Jianmin Fang
求助PDF
{"title":"342 Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase II clinical study","authors":"Lingying Wu, Guiling Li, Youzhong Zhang, Ruifang An, Li Sun, Keqiang Zhang, Yi Huang, Ruixia Guo, Qingshui Li, Jinwei Miao, A. Lin, Jianlin Yuan, G. Lou, Hongying Yang, Yu Zhang, Hui Zhang, Aiqin He, Junying Tang, Jianming Ying, Yun Ling, Jianmin Fang","doi":"10.1136/ijgc-2024-esgo.10","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"477 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
引用
批量引用
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
